Bear Market Rally Lifts HealthCare Stocks

Pixabay

Use the values below to gauge your portfolio and Healthcare sector performance for 2022. They represent what we hope will be near the 2022 bottom given that the valuations are not too rich. The XLV was up 2.26% to $122.60 near last week’s bottom of $120. Last week was one of the worst in 2022. If your stock was not up today, expect the worst because all major indices were up over 2%.

A case in point was CRISPR Therapeutics (CRSP) down 7.61% during a Company Meeting that must have disappointed investors. It’s not clear what happened or what news came out?

Many of our favorite small cap stocks rallied today and here are some that look good for the long term:  EVH, CCXI, CYRX, MDGL, MRNA, MRTX, VCYT.  But clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. So we bought some pricey Eli Lilly (LLY) today because of their new diabetes drugs.

Also look at United Health (UNH) up 6.25% to $489 today and way off 2022 highs of $553.